000119448 001__ 119448
000119448 005__ 20240228134941.0
000119448 0247_ $$2doi$$a10.1159/000365496
000119448 0247_ $$2pmid$$apmid:25231686
000119448 0247_ $$2ISSN$$a0378-584X
000119448 0247_ $$2ISSN$$a1423-0240
000119448 0247_ $$2ISSN$$a2296-5262
000119448 0247_ $$2ISSN$$a2296-5270
000119448 037__ $$aDKFZ-2017-00190
000119448 041__ $$aeng
000119448 082__ $$a610
000119448 1001_ $$0P:(DE-HGF)0$$aAl-Taee, Khamael K$$b0$$eFirst author
000119448 245__ $$aMetastasis-related processes show various degrees of activation in different stages of pancreatic cancer rat liver metastasis.401
000119448 260__ $$aBasel$$bKarger$$c2014
000119448 3367_ $$2DRIVER$$aarticle
000119448 3367_ $$2DataCite$$aOutput Types/Journal article
000119448 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1487846757_9693
000119448 3367_ $$2BibTeX$$aARTICLE
000119448 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000119448 3367_ $$00$$2EndNote$$aJournal Article
000119448 520__ $$aMost pancreatic ductal adenocarcinoma (PDAC) patients who undergo tumor resection will develop postoperative liver metastasis within the first 2 years. Our hypothesis was that, during liver colonization, the temporal modulation of processes related to metastasis will change in a specific manner and that information on these changes might be used for new therapeutic approaches.PDAC rat ASML cells were inoculated into the liver of BDX rats and re-isolated after different time periods of liver colonization (early, intermediate, advanced, and terminal). The total RNA of these samples was used to evaluate the expression profiles of more than 23,000 genes by chip array analysis.Depending on the time span following re-isolation, 7-15% of all known genes were deregulated. These genes were assigned to metastasis-related processes during the 4 stages of colonization. Except for apoptosis, all other processes were not activated in the early and middle colonization stages. In the terminal phase of liver colonization, cell proliferation, cell homing, cell movement, and vasculogenesis were significantly activated.We hypothesize that targeting the relatively few deregulated genes in the early stage of liver colonization could ultimately improve the survival of PDAC patients.
000119448 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000119448 588__ $$aDataset connected to CrossRef, PubMed,
000119448 650_7 $$2NLM Chemicals$$aNeoplasm Proteins
000119448 7001_ $$0P:(DE-He78)d861e207ca85f7e171d3225d4a4536cd$$aAnsari, Shariq Suhail$$b1$$udkfz
000119448 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b2$$udkfz
000119448 7001_ $$0P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aBerger, Martin$$b3$$udkfz
000119448 7001_ $$0P:(DE-HGF)0$$aAdwan, Hassan$$b4$$eLast author
000119448 773__ $$0PERI:(DE-600)2749752-5$$a10.1159/000365496$$gVol. 37, no. 9, p. 464 - 470$$n9$$p464 - 470$$tOncology research and treatment$$v37$$x2296-5262$$y2014
000119448 909CO $$ooai:inrepo02.dkfz.de:119448$$pVDB
000119448 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000119448 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d861e207ca85f7e171d3225d4a4536cd$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000119448 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000119448 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000119448 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000119448 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000119448 9141_ $$y2014
000119448 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000119448 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000119448 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000119448 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000119448 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000119448 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOL RES TREAT : 2015
000119448 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000119448 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000119448 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000119448 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000119448 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000119448 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000119448 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000119448 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000119448 9201_ $$0I:(DE-He78)G401-20160331$$kG401$$lToxikologie und Chemotherapie$$x0
000119448 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x1
000119448 980__ $$ajournal
000119448 980__ $$aVDB
000119448 980__ $$aI:(DE-He78)G401-20160331
000119448 980__ $$aI:(DE-He78)C060-20160331
000119448 980__ $$aUNRESTRICTED